Global Digital Pathology Market

Digital Pathology Market Size, Share, Growth Analysis, By Product(Software {Type [Integrated and Standalone (Information Management System and Image Analysis Software)], By Deployment Mode (On Premises and Cloud Based)}, Scanners (Brightfield Scanners and Other Scanners), Device), By Application(Drug discovery & development, academic research, and disease diagnosis), By Type(Human pathology, Veterinary pathology), By End user(Pharmaceutical and biotechnology, Hospitals & Reference Laboratories, Academic & Research Institutes), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35G2172 | Region: Global | Published Date: August, 2024
Pages: 219 | Tables: 115 | Figures: 77

Digital Pathology Market Regional Insights

Due to its highly developed healthcare systems, sophisticated technology uptake and substantial investment in research and development, North America is the global leader in digital pathology. The region has an abundance of top-notch tech firms and an ecosystem which encourages growths in digital pathology innovations. Also, the North American healthcare services are directed towards enhancing accuracy in diagnosis as well as efficiency; thus, fueling the need for these digital solutions. Government support for healthcare IT advancements, coupled with the growing prevalence of chronic diseases, further fuels digital pathology market growth, positioning North America as a leader in the digital pathology sector. 

The swiftest growth of any region in the global digital pathology market trade is Asia-Pacific, due to advancements made in its healthcare systems, growing capital outlay on biomedical machineries and enhancing diagnostic operations. In this part of the earth, the high number of individuals and the rising rates of persistent illnesses lead to a need for effective diagnostic measures that are also precise. Currents Asian states along with individual agencies have a direct involvement in fostering digital health initiatives while simultaneously increasing investments into research on the subject. Further, the increasing public expenditure on health care together with an elaborate structure of healthcare service providers within this region are some determinants of speed found within such growing field.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Digital Pathology Market size was valued at USD 1051.59 million in 2022 and is poised to grow from USD 1133.61 million in 2023 to USD 2067.36 million by 2031, at a CAGR of 7.8% during the forecast period (2024-2031).

The fluctuating context of the global digital pathology market brings competition among its major players, inspiring innovation and progress. At the forefront of this sector are international giants like Philips Healthcare, Leica Biosystems, and Nikon Instruments who provide cutting-edge digital imaging and analytical tools. These firms focus on enhancing diagnostic accuracy, integrating AI, and expanding their technological offerings. The competition fosters rapid advancements and diverse solutions, catering to the increasing demand for efficient and precise pathology diagnostics worldwide. 'Philips Healthcare (Netherlands) ', 'Roche Diagnostics (Switzerland) ', 'Hamamatsu Photonics (Japan) ', '3DHISTECH (Hungary) ', 'GE Healthcare (US) ', 'Apollo Enterprise Imaging (US) ', 'Olympus Corporation (Japan) ', 'Mikroscan Technologies (US) ', 'Inspirata (US) ', 'PerkinElmer (US) ', 'Huron Digital Pathology (Canada) ', 'Sectra AB (Sweden) ', 'PathAI (US) ', 'Indica Labs (US) ', 'F. Hoffmann-La Roche (Switzerland) ', 'Nikon Corporation (Japan) ', 'Danaher Corporation (US) ', 'Visiopharm (Denmark) ', 'Densitas (Canada) ', 'Objective Pathology (US) ', 'QPath (US)'

Technological innovations such as whole-slide imaging (WSI), image analysis tools, and artificial intelligence (AI) have completely transformed digital pathology. As a result of these progressions, digital pathology is increasingly favored by healthcare providers on account of improved diagnosis accuracy, operational efficiency and automated workflow processes. 

Rise of Fully Cloud-Based Digital Pathology for Scalable, Collaborative, and Personalized Healthcare: The global digital pathology market has experienced tremendous growth owing to recent progressions in technology alongside increasing demands for eco-friendly diagnostic possibilities. Digital photography can be used for the collection, management, and analysis of pathological data. The widespread use of Whole Slide Imaging (WSI), which enables pathologists to view entire tissue slides digitally, is an impressive trend. 

Due to its highly developed healthcare systems, sophisticated technology uptake and substantial investment in research and development, North America is the global leader in digital pathology. The region has an abundance of top-notch tech firms and an ecosystem which encourages growths in digital pathology innovations. Also, the North American healthcare services are directed towards enhancing accuracy in diagnosis as well as efficiency; thus, fueling the need for these digital solutions. Government support for healthcare IT advancements, coupled with the growing prevalence of chronic diseases, further fuels digital pathology market growth, positioning North America as a leader in the digital pathology sector. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Digital Pathology Market

Report ID: SQMIG35G2172

$5,300
BUY NOW GET FREE SAMPLE